How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code SAF: Integrated Continuous Glucose Monitor For Non-Intensive Glucose Monitoring, Over-The-Counter. View classification details, related manufacturers, 510(k) clearances, and recall records.
An integrated continuous glucose monitoring system (iCGM) for non-intensive glucose monitoring is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time to detect euglycemic and dysglycemic glucose levels in persons who are not on insulin and do not have a significant risk of problematic hypoglycemia. iCGM systems for non-intensive glucose monitoring are designed to reliably and securely transmit glucose measurement data to digitally connected devices, excluding devices intended to control the delivery of insulin, and are intended to be used alone or in conjunction with these digitally connected medical devices. Device output should not be used to make treatment decisions without consulting with a qualified healthcare professional.Explore clinical chemistry records →
4 clearance records and 0 recall records in the covered releases, across 3 source company names and 1 product codes. Dated history runs from Mar 5, 2024 to May 21, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| SAF · Integrated Continuous Glucose Monitor For Non-Intensive Glucose Monitoring, Over-The-Counter | 4 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Stelo Glucose Biosensor SystemK261359 · SAF | Dexcom, Inc. | 510(k) | May 21, 2026FDA decision date |
| Signos Glucose Monitoring SystemK250106 · SAF | Signos, Inc. | 510(k) | Mar 21, 2025FDA decision date |
| Lingo Glucose SystemK233655 · SAF | Abbott | 510(k) | May 29, 2024FDA decision date |
| Stelo Glucose Biosensor SystemK234070 · SAF | Dexcom, Inc. | 510(k) | Mar 5, 2024FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 21, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.